APADAMTASE ALFA

APADAMTASE ALFA was reported 79 times

APADAMTASE ALFA is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CONGENITAL THROMBOTIC THROMBOCYTOPENIC PURPURA 1 0.2000
1 ADAMTS13 ACTIVITY INCREASED 1 0.1250
2 UMBILICAL CORD THROMBOSIS 1 0.0556
3 INHIBITING ANTIBODIES POSITIVE 3 0.0526
4 GIANT CELL TUMOUR OF TENDON SHEATH 1 0.0227
5 ADAMTS13 ACTIVITY DECREASED 4 0.0154
6 PRODUCT RECONSTITUTION QUALITY ISSUE 3 0.0034
7 TONIC CONVULSION 4 0.0028
8 DRUG LEVEL ABNORMAL 1 0.0019
9 VULVOVAGINAL INJURY 1 0.0018
10 BODY TEMPERATURE ABNORMAL 3 0.0016
11 THROMBOTIC THROMBOCYTOPENIC PURPURA 5 0.0014
12 OXYGEN SATURATION ABNORMAL 4 0.0014
13 BREAST FEEDING 1 0.0013
14 PLACENTAL INSUFFICIENCY 1 0.0012
15 DYSCHROMATOPSIA 1 0.0012
16 MATERNAL EXPOSURE DURING DELIVERY 1 0.0010
17 HAEMOLYSIS 6 0.0008
18 PREGNANCY 13 0.0006
19 VEIN RUPTURE 1 0.0006
20 MIOSIS 4 0.0005
21 PANCREATITIS NECROTISING 1 0.0004
22 METASTASES TO PERITONEUM 1 0.0004
23 BLOOD POTASSIUM ABNORMAL 1 0.0004
24 LARYNGOSPASM 1 0.0004
25 MIGRAINE WITH AURA 1 0.0004
26 LUNG ADENOCARCINOMA 1 0.0003
27 MYDRIASIS 4 0.0003
28 PLATELET COUNT INCREASED 4 0.0003
29 PARANASAL SINUS DISCOMFORT 1 0.0003
30 VULVOVAGINAL MYCOTIC INFECTION 1 0.0003
31 BLOOD LACTATE DEHYDROGENASE INCREASED 4 0.0003
32 LOW BIRTH WEIGHT BABY 2 0.0003
33 EXPOSURE VIA BREAST MILK 1 0.0003
34 IRON DEFICIENCY 1 0.0002
35 PRODUCT DISTRIBUTION ISSUE 2 0.0002
36 VAGINAL INFECTION 1 0.0002
37 BLOOD URINE PRESENT 4 0.0002
38 PRE-ECLAMPSIA 1 0.0002
39 BLOOD PRESSURE ABNORMAL 4 0.0002
40 POOR VENOUS ACCESS 2 0.0002
41 NEUROLOGICAL SYMPTOM 1 0.0002
42 VENTRICULAR SEPTAL DEFECT 1 0.0002
43 MENISCUS INJURY 1 0.0002
44 UNRESPONSIVE TO STIMULI 4 0.0002
45 CORONAVIRUS INFECTION 1 0.0002
46 JAUNDICE 4 0.0001
47 BLOOD BILIRUBIN INCREASED 4 0.0001
48 PALLOR 4 0.0001
49 FEELING COLD 4 0.0001
50 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
51 METABOLIC ACIDOSIS 4 0.0001
52 CEREBRAL INFARCTION 3 0.0001
53 GASTROINTESTINAL INFECTION 1 0.0001
54 INCREASED TENDENCY TO BRUISE 1 0.0001
55 OVARIAN CANCER 1 0.0001
56 THROMBOTIC MICROANGIOPATHY 1 0.0001
57 BODY TEMPERATURE DECREASED 1 0.0001
58 OVARIAN CYST 1 0.0001
59 DRUG LEVEL DECREASED 1 0.0001
60 WEIGHT FLUCTUATION 1 0.0001
61 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
62 BREAST PAIN 1 0.0001
63 PULMONARY OEDEMA 4 0.0001
64 BLOOD TEST ABNORMAL 1 0.0001
65 INSURANCE ISSUE 1 0.0001
66 BRAIN FOG 1 0.0001
67 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
68 ISCHAEMIC STROKE 1 0.0001
69 NO ADVERSE EVENT 10 0.0001
70 THROMBOCYTOPENIA 6 0.0001
71 PHOTOPHOBIA 1 0.0001
72 PROTEINURIA 1 0.0001
73 PRESCRIBED OVERDOSE 1 0.0001
74 ABORTION SPONTANEOUS 2 0.0000
75 EXTRA DOSE ADMINISTERED 2 0.0000
76 CARDIAC ARREST 4 0.0000
77 PRODUCT DISPENSING ERROR 1 0.0000
78 PRODUCT AVAILABILITY ISSUE 1 0.0000
79 DEVICE MALFUNCTION 3 0.0000
80 ABDOMINAL DISTENSION 4 0.0000
81 HAEMORRHAGE 4 0.0000
82 PREMATURE BABY 1 0.0000
83 LACRIMATION INCREASED 1 0.0000
84 EXPOSURE DURING PREGNANCY 2 0.0000
85 NERVOUS SYSTEM DISORDER 1 0.0000
86 LOSS OF CONSCIOUSNESS 4 0.0000
87 VIRAL INFECTION 1 0.0000
88 FUNGAL INFECTION 1 0.0000
89 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 1 0.0000
90 HAEMATURIA 1 0.0000
91 UNDERDOSE 2 0.0000
92 DYSARTHRIA 1 0.0000
93 NEUTROPHIL COUNT DECREASED 1 0.0000
94 DEVICE LEAKAGE 1 0.0000
95 VAGINAL HAEMORRHAGE 1 0.0000
96 THERAPY NON-RESPONDER 1 0.0000
97 INCORRECT DOSE ADMINISTERED 5 0.0000
98 DISEASE RECURRENCE 1 0.0000
99 MIGRAINE 2 0.0000
100 EYE IRRITATION 1 0.0000
101 PRODUCT DOSE OMISSION ISSUE 5 0.0000
102 THERAPEUTIC RESPONSE DECREASED 1 0.0000
103 FEELING HOT 1 0.0000
104 NEOPLASM MALIGNANT 1 0.0000
105 CEREBROVASCULAR ACCIDENT 2 0.0000
106 TACHYCARDIA 1 0.0000
107 NASOPHARYNGITIS 2 0.0000
108 PRODUCT USE ISSUE 2 0.0000
109 FLUSHING 1 0.0000
110 HYPERTENSION 2 0.0000
111 ASTHMA 1 0.0000
112 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
113 ABDOMINAL PAIN 2 0.0000
114 VOMITING 4 0.0000
115 VISUAL IMPAIRMENT 1 0.0000
116 HEADACHE 5 0.0000
117 MALAISE 3 0.0000
118 BLOOD PRESSURE INCREASED 1 0.0000
119 NAUSEA 5 0.0000
120 CONFUSIONAL STATE 1 0.0000
121 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
122 SOMNOLENCE 1 0.0000
123 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
124 ABDOMINAL PAIN UPPER 1 0.0000
125 WEIGHT INCREASED 1 0.0000
126 DEPRESSION 1 0.0000
127 DRUG INEFFECTIVE 5 0.0000
128 COUGH 1 0.0000
129 PAIN IN EXTREMITY 1 0.0000
130 FALL 1 0.0000
131 PYREXIA 1 0.0000
132 ASTHENIA 1 0.0000
133 PRURITUS 1 0.0000
134 ARTHRALGIA 1 0.0000
135 OFF LABEL USE 2 0.0000
136 DIZZINESS 1 0.0000
137 PAIN 1 0.0000
138 DEATH 1 0.0000